2021-01-06,Seelos Therapeutics Announces Year End 2020 Business Update
2021-01-05,Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-12-21,Seelos Therapeutics Announces Issuance of a Patent for Trehalose (SLS-005) in Israel
2020-12-15,Seelos Therapeutics Announces the Selection of SLS-005 (Trehalose) for the HEALEY ALS Platform Trial for Amyotrophic Lateral Sclerosis Led by the Harvard Medical School
2020-12-14,Seelos Therapeutics Raises $10 Million In Private Placement of Senior Secured Convertible Note
2020-12-11,Seelos Therapeutics Seeks Suicide Solution in Ketamine
2020-12-08,Seelos Therapeutics to Participate in the 10th Annual LifeSci Partners Corporate Access Event
2020-12-02,Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-11-29,"Is Seelos Therapeutics, Inc. (SEEL) A Good Stock To Buy Now?"
2020-11-19,Seelos Therapeutics Receives US Orphan Drug Designation for SLS-005 (Trehalose) in Amyotrophic Lateral Sclerosis
2020-11-09,Seelos Therapeutics to Participate in the 3rd International Conference on Sanfilippo Syndrome and Related Diseases
2020-10-26,Seelos Therapeutics Announces Issuance of Composition of Matter Patent for SLS-007
2020-10-22,Seelos Therapeutics to Participate in Investor Conferences in November
2020-09-28,"These 2 Penny Stocks Are Poised for a Massive Rally, Says Roth Capital"
2020-09-23,Seelos Therapeutics Announces Sponsored Research Agreement with Duke University for Gene Therapy Studies of SLS-004 in Parkinson's Disease
2020-09-14,Seelos Announces Issuance of a New Patent and an Additional Notice of Allowance in Japan for Intranasal Racemic Ketamine (SLS-002)
2020-09-10,Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005)
2020-09-09,Seelos Therapeutics Announces Closing of $7.0 Million Registered Direct Offering
2020-09-04,Seelos Therapeutics Announces Pricing of $7.0 Million Registered Direct Offering
2020-08-28,Seelos Therapeutics to Participate in the Cantor Virtual Global Healthcare Conference
2020-08-25,Seelos Therapeutics Receives European Orphan Drug Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome
2020-08-10,Seelos Therapeutics Receives FDA May Proceed Notice to Initiate a Phase IIb/III Trial of SLS-005 in Amyotrophic Lateral Sclerosis
2020-07-21,Seelos Therapeutics Receives Positive EMA Opinion on Orphan Drug Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome
2020-07-16,Seelos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2020-07-16,Seelos Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2020-06-25,Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-007 in Parkinson's Disease
2020-06-23,Seelos Therapeutics Announces Final Data from Phase I PK/PD Study of Intranasal Racemic Ketamine (SLS-002) and Clinical Development Plans
2020-06-17,"Seelos Therapeutics, Inc. (NASDAQ:SEEL): When Will It Breakeven?"
2020-06-15,Seelos Therapeutics to Host Key Opinion Leader Call to Discuss Phase I Data and Upcoming Trial Design for SLS-002
2020-06-04,"Hedge Funds Warming Up To Seelos Therapeutics, Inc. (SEEL)"
2020-05-28,Seelos Therapeutics Announces Initiation of Preclinical Study of SLS-004 in Parkinsons Disease
2020-05-19,"INVESTIGATION ALERT: Fields Kupka & Shukurov LLP Is Investigating Seelos Therapeutics, Inc. for Potential Breach of Fiduciary Duty Claims."
2020-05-19,Seelos Therapeutics to Host Key Opinion Leader Call to Discuss the Unmet Medical Needs in Suicide and Depression
2020-05-18,Seelos Therapeutics to Participate in the Benchmark Healthcare Virtual Conference
2020-05-15,Seelos Therapeutics Announces Appointment of Judith Dunn to the Board of Directors
2020-05-15,Seelos Therapeutics Receives Rare Pediatric Disease Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome
2020-05-12,Seelos Therapeutics to Participate in the Jefferies Virtual Healthcare Conference
2020-05-04,Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005)
2020-04-30,Seelos Therapeutics Receives Orphan Drug Designation for SLS-005 (Trehalose) in Sanfilippo Syndrome
2020-04-08,Seelos Therapeutics Provides Q1 2020 Business Update and Pipeline Developments
2020-03-24,Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)
2020-03-16,Seelos Therapeutics Announces Closing of Public Offering of Common Stock
2020-03-11,Seelos Therapeutics Announces Pricing of $4.5 Million Public Offering of Common Stock
2020-03-11,Seelos Therapeutics Announces Proposed Public Offering of Common Stock
2020-03-11,Seelos Therapeutics Announces European Medicines Agency Guidance to Design an Open-Label Pivotal Study for SLS-005 in Sanfilippo Syndrome
2020-03-06,Seelos Therapeutics Receives Notice of Allowance for Composition of Matter Patent for SLS-007
2020-02-26,Seelos Therapeutics Announces Additional Interim Data from Phase I Studies of Intranasal Racemic Ketamine (SLS-002)
2020-02-19,Seelos Therapeutics to Participate in Two Upcoming Investor Conferences in March
2020-02-17,"Raj Mehra Is The Founder of Seelos Therapeutics, Inc. (NASDAQ:SEEL) And They Just Spent US$100k On Shares"
2020-02-13,Seelos Therapeutics Announces Closing of Public Offering of Common Stock
2020-02-10,Seelos Therapeutics Announces Pricing of $5 Million Public Offering of Common Stock
2020-01-28,Did You Manage To Avoid Seelos Therapeutics's (NASDAQ:SEEL) Devastating 73% Share Price Drop?
2020-01-28,Seelos Therapeutics Announces Update to Parkinsons Disease Program SLS-007
2020-01-22,Seelos Therapeutics Announces Updates to SLS-005 (trehalose) Programs for Europe and U.S.
2020-01-10,Sorrento shares rise on private equity proposal
2020-01-10,Seelos Therapeutics Announces Interim Data from Phase I Study of Intranasal Racemic Ketamine (SLS-002)
2020-01-06,Seelos Therapeutics Schedules Type C Meeting with FDA to Discuss Intranasal Racemic Ketamine Program (SLS-002)
2019-12-16,Sorrento Announces Dr. Robin Smith as New Member of the Board of Directors
2019-12-13,Seelos Therapeutics to Participate in 33rd Annual National MPS Society Family Conference
2019-12-04,Seelos Therapeutics Receives Notice of Allowance for an Additional US Patent for Trehalose (SLS-005)
2019-11-30,"Hedge Funds Have Never Been More Bullish On Seelos Therapeutics, Inc. (SEEL)"
2019-11-27,Seelos Therapeutics Announces Dosing of Phase I PK/PD Study of Intranasal Racemic Ketamine (SLS-002)
2019-11-20,Seelos Therapeutics Announces Initial Dosing of Phase I DDI Study of Intranasal Racemic Ketamine (SLS-002)
2019-11-18,Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)
2019-11-08,Seelos Therapeutics Reports Q3 2019 Pipeline Update
2019-11-01,Seelos Therapeutics to Participate in Upcoming Investor Conferences in December
2019-10-21,Seelos Therapeutics Announces Amendment of SLS-002 Agreement
2019-10-18,Seelos Therapeutics to Participate in Upcoming Investor Conference in November
2019-10-15,Seelos Therapeutics Announces the Addition of Scott Applebaum as Lead Strategic Regulatory Consultant
2019-09-04,Seelos Therapeutics to Participate in Upcoming Investor Conference in September
2019-08-23,Seelos Therapeutics Announces Pricing of $6.7 Million Registered Direct Offering
2019-08-22,"What Kind Of Investor Owns Most Of Seelos Therapeutics, Inc. (NASDAQ:SEEL)?"
2019-08-22,Seelos Therapeutics Announces FDA Acceptance of IND Application for SLS-005 for Mucopolysaccharidosis Type III (Sanfilippo Syndrome)
2019-08-14,Seelos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2019-08-06,Seelos Therapeutics to Ring Opening Bell at Nasdaq on August 12th
2019-08-01,Seelos Therapeutics Reports Q2 2019 Pipeline Update
2019-07-17,Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
2019-07-15,Seelos Therapeutics Announces Receipt of a Grant for Funding of SLS-005 Program
2019-07-02,Seelos Therapeutics Receives Notice of Allowance for a US Patent for SLS-005 in New Indication of Friedreich Ataxia
2019-07-01,Seelos Therapeutics Added to Russell MicrocapÂ® Index
2019-06-28,"A Look At Benzinga Pro's Most-Searched Tickers For June 28, 2019"
2019-06-27,Seelos Therapeutics Announces Acquisition of an Exclusive Worldwide License of Gene Therapy Program to Address Parkinsons Disease from Duke University
2019-06-06,Seelos Therapeutics Provides Update on Pipeline Developments and Corporate Highlights
2019-05-21,Seelos Therapeutics Reports Q1 2019 Pipeline Update
2019-04-16,Seelos Therapeutics to Participate at the Jefferies 2019 Global Healthcare Conference in NYC
2019-04-02,"Two Months into a Reverse Merger, Where Does Seelos Therapeutics Stand Now?"
2019-03-29,Why Seelos Therapeutics Shares Are Surging Out Of The Gate
2019-03-28,Seelos Therapeutics Provides Update on Pipeline Developments and Corporate Highlights
2019-03-27,Four Healthcare Stocks Picking Up Speed on Wednesday
2019-03-13,A Near Term FDA Clearance That Could Be The Beginning Of The Brain-Computer Revolution?
2019-03-08,Shares of Seelos Therapeutics up 80% Friday morning
2019-03-08,Four Healthcare Stocks Looking To Close Out a Strong Week on Friday
2019-03-07,Seelos Therapeutics Announces Acquisition of an Exclusive License to Intellectual Property from The UC Regents to Potential Disease-Modifying Parkinson's Disease Therapy Created at UCLA
2019-03-06,Four Tech Stocks To Watch on Wednesday
2019-03-06,Seelos Therapeutics to Webcast Presentation at the 39th Annual Cowen Health Care Conference and Participate in the 31st Annual ROTH Conference
2019-03-01,Seelos Therapeutics to Present at the 39th Annual Cowen Health Care Conference
2019-02-19,Seelos Therapeutics Completes Acquisition of Trehalose from Bioblast Pharma
